Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Sjögren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.

Ruacho G, Kvarnström M, Zickert A, Oke V, Rönnelid J, Eketjäll S, Elvin K, Gunnarsson I, Svenungsson E.

J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250. [Epub ahead of print]

2.

Epilepsy in Systemic lupus erythematosus: Prevalence and risk factors.

Hopia L, Andersson M, Svenungsson E, Khademi M, Piehl F, Tomson T.

Eur J Neurol. 2019 Aug 27. doi: 10.1111/ene.14077. [Epub ahead of print]

PMID:
31454130
3.

Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.

Elbagir S, Elshafie AI, Elagib EM, Mohammed NA, Aledrissy MIE, Sohrabian A, Nur MAM, Svenungsson E, Gunnarsson I, Rönnelid J.

Rheumatology (Oxford). 2019 Aug 14. pii: kez323. doi: 10.1093/rheumatology/kez323. [Epub ahead of print]

PMID:
31411331
4.

Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Svenungsson E, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2019 Aug 7. doi: 10.1002/art.41070. [Epub ahead of print]

PMID:
31390162
5.

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Tengvall K, Huang J, Hellström C, Kammer P, Biström M, Ayoglu B, Lima Bomfim I, Stridh P, Butt J, Brenner N, Michel A, Lundberg K, Padyukov L, Lundberg IE, Svenungsson E, Ernberg I, Olafsson S, Dilthey AT, Hillert J, Alfredsson L, Sundström P, Nilsson P, Waterboer T, Olsson T, Kockum I.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16955-16960. doi: 10.1073/pnas.1902623116. Epub 2019 Aug 2.

PMID:
31375628
6.

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Odqvist L, Jevnikar Z, Riise R, Öberg L, Rhedin M, Leonard D, Yrlid L, Jackson S, Mattsson J, Nanda S, Cohen P, Knebel A, Arthur S, Thörn K, Svenungsson E, Jönsen A, Gunnarsson I, Tandre K, Alexsson A, Kastbom A, Rantapää-Dahlqvist S, Eloranta ML, Syvänen AC, Bengtsson A, Johansson P, Sandling JK, Sjöwall C, Rönnblom L, Collins B, Vaarala O.

Ann Rheum Dis. 2019 Oct;78(10):1363-1370. doi: 10.1136/annrheumdis-2019-215434. Epub 2019 Jul 12.

7.

Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study.

Norhammar A, Kjellström B, Habib N, Gustafsson A, Klinge B, Nygren Å, Näsman P, Svenungsson E, Rydén L.

Diabetes Care. 2019 Aug;42(8):1504-1511. doi: 10.2337/dc19-0018. Epub 2019 Jun 10.

PMID:
31182493
8.

Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.

Idborg H, Zandian A, Ossipova E, Wigren E, Preger C, Mobarrez F, Checa A, Sohrabian A, Pucholt P, Sandling JK, Fernandes-Cerqueira C, Rönnelid J, Oke V, Grosso G, Kvarnström M, Larsson A, Wheelock CE, Syvänen AC, Rönnblom L, Kultima K, Persson H, Gräslund S, Gunnarsson I, Nilsson P, Svenungsson E, Jakobsson PJ.

Front Immunol. 2019 May 17;10:1029. doi: 10.3389/fimmu.2019.01029. eCollection 2019.

9.

Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes.

Mobarrez F, Fuzzi E, Gunnarsson I, Larsson A, Eketjäll S, Pisetsky DS, Svenungsson E.

J Autoimmun. 2019 Aug;102:142-149. doi: 10.1016/j.jaut.2019.05.003. Epub 2019 May 16.

PMID:
31103269
10.

EULAR recommendations for the management of antiphospholipid syndrome in adults.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM.

Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15.

PMID:
31092409
11.

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.

Oke V, Gunnarsson I, Dorschner J, Eketjäll S, Zickert A, Niewold TB, Svenungsson E.

Arthritis Res Ther. 2019 Apr 29;21(1):107. doi: 10.1186/s13075-019-1878-y.

12.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
13.

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.

Idborg H, Zandian A, Sandberg AS, Nilsson B, Elvin K, Truedsson L, Sohrabian A, Rönnelid J, Mo J, Grosso G, Kvarnström M, Gunnarsson I, Lehtiö J, Nilsson P, Svenungsson E, Jakobsson PJ.

Arthritis Res Ther. 2019 Feb 18;21(1):62. doi: 10.1186/s13075-019-1836-8.

14.

Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.

Estelius J, Lengqvist J, Ossipova E, Idborg H, Le Maître E, Andersson MLA, Brundin L, Khademi M, Svenungsson E, Jakobsson PJ, Lampa J.

Arthritis Res Ther. 2019 Feb 15;21(1):60. doi: 10.1186/s13075-019-1846-6.

15.

Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.

Torell F, Eketjäll S, Idborg H, Jakobsson PJ, Gunnarsson I, Svenungsson E, Trygg J.

J Proteome Res. 2019 Mar 1;18(3):1208-1217. doi: 10.1021/acs.jproteome.8b00811. Epub 2019 Feb 18.

PMID:
30742448
16.

Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.

Almlöf JC, Nystedt S, Leonard D, Eloranta ML, Grosso G, Sjöwall C, Bengtsson AA, Jönsen A, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Hum Genet. 2019 Feb;138(2):141-150. doi: 10.1007/s00439-018-01966-7. Epub 2019 Feb 1.

17.

A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts.

Farias FHG, Dahlqvist J, Kozyrev SV, Leonard D, Wilbe M, Abramov SN, Alexsson A, Pielberg GR, Hansson-Hamlin H, Andersson G, Tandre K, Bengtsson AA, Sjöwall C, Svenungsson E, Gunnarsson I, Rantapää-Dahlqvist S, Syvänen AC, Sandling JK, Eloranta ML, Rönnblom L, Lindblad-Toh K.

Eur J Hum Genet. 2019 Mar;27(3):432-441. doi: 10.1038/s41431-018-0297-x. Epub 2018 Nov 20.

18.

Obstetric antiphospholipid syndrome.

Antovic A, Sennström M, Bremme K, Svenungsson E.

Lupus Sci Med. 2018 Sep 25;5(1):e000197. doi: 10.1136/lupus-2016-000197. eCollection 2018. Review.

19.

Antiphospholipid Antibodies in Patients With Myocardial Infarction.

Grosso G, Sippl N, Kjellström B, Amara K, de Faire U, Elvin K, Lindahl B, Näsman P, Rydén L, Norhammar A, Svenungsson E.

Ann Intern Med. 2019 Feb 19;170(4):277-280. doi: 10.7326/M18-2130. Epub 2018 Oct 23. No abstract available.

PMID:
30357274
20.

Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.

Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.

Clin Exp Immunol. 2018 Oct;194(1):27-38. doi: 10.1111/cei.13180. Epub 2018 Sep 12.

PMID:
30208508
21.

Muscle endurance, strength, and active range of motion in patients with different subphenotypes in systemic sclerosis: a cross-sectional cohort study.

Pettersson H, Boström C, Bringby F, Walle-Hansen R, Jacobsson L, Svenungsson E, Nordin A, Alexanderson H.

Scand J Rheumatol. 2019 Mar;48(2):141-148. doi: 10.1080/03009742.2018.1477990. Epub 2018 Aug 2.

PMID:
30070598
22.

Microparticles as autoantigens in systemic lupus erythematosus.

Mobarrez F, Svenungsson E, Pisetsky DS.

Eur J Clin Invest. 2018 Dec;48(12):e13010. doi: 10.1111/eci.13010. Epub 2018 Oct 21.

PMID:
30062774
23.

Dr. Rossides, et al reply.

Rossides M, Simard JF, Svenungsson E, VON Euler M, Arkema EV.

J Rheumatol. 2018 Jul;45(7):1070. doi: 10.3899/jrheum.180122. No abstract available.

PMID:
29961679
24.

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.

Idborg H, Eketjäll S, Pettersson S, Gustafsson JT, Zickert A, Kvarnström M, Oke V, Jakobsson PJ, Gunnarsson I, Svenungsson E.

Lupus Sci Med. 2018 Jun 4;5(1):e000260. doi: 10.1136/lupus-2018-000260. eCollection 2018.

25.

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.

Åkesson K, Pettersson S, Ståhl S, Surowiec I, Hedenström M, Eketjäll S, Trygg J, Jakobsson PJ, Gunnarsson I, Svenungsson E, Idborg H.

Lupus Sci Med. 2018 May 23;5(1):e000254. doi: 10.1136/lupus-2017-000254. eCollection 2018. Erratum in: Lupus Sci Med. 2019 May 17;6(1):e000254corr1.

26.

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL.

Parodis I, Söder F, Faustini F, Kasza Z, Samuelsson I, Zickert A, Svenungsson E, van Vollenhoven RF, Malmström V, Wermeling F, Gunnarsson I.

Lupus. 2018 Aug;27(9):1470-1478. doi: 10.1177/0961203318777116. Epub 2018 May 21.

PMID:
29783918
27.

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.

Leonard D, Svenungsson E, Dahlqvist J, Alexsson A, Ärlestig L, Taylor KE, Sandling JK, Bengtsson C, Frodlund M, Jönsen A, Eketjäll S, Jensen-Urstad K, Gunnarsson I, Sjöwall C, Bengtsson AA, Eloranta ML, Syvänen AC, Rantapää-Dahlqvist S, Criswell LA, Rönnblom L.

Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.

28.

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman GJ, Svenungsson E, Grönwall C.

Arthritis Res Ther. 2018 Feb 26;20(1):36. doi: 10.1186/s13075-018-1530-2.

29.

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus.

Imgenberg-Kreuz J, Carlsson Almlöf J, Leonard D, Alexsson A, Nordmark G, Eloranta ML, Rantapää-Dahlqvist S, Bengtsson AA, Jönsen A, Padyukov L, Gunnarsson I, Svenungsson E, Sjöwall C, Rönnblom L, Syvänen AC, Sandling JK.

Ann Rheum Dis. 2018 May;77(5):736-743. doi: 10.1136/annrheumdis-2017-212379. Epub 2018 Feb 1.

30.

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.

Wigren M, Svenungsson E, Mattisson IY, Gustafsson JT, Gunnarsson I, Zickert A, Elvin K, Jensen-Urstad K, Bengtsson A, Gullstrand B, Fredrikson GN, Nilsson J.

Atherosclerosis. 2018 Mar;270:1-7. doi: 10.1016/j.atherosclerosis.2018.01.022. Epub 2018 Jan 17.

PMID:
29407876
31.

Response to: 'Increased stroke incidence in systemic lupus erythematosus patients: risk factors or disease itself?' by Bruzzese and Zullo.

Arkema EV, Rossides M, Von Euler M, Svenungsson E, Sjöwall C, Simard JF.

Ann Rheum Dis. 2018 Oct;77(10):e72. doi: 10.1136/annrheumdis-2017-212604. Epub 2017 Nov 16. No abstract available.

PMID:
29146744
32.

Depressed serum IgM levels in SLE are restricted to defined subgroups.

Grönwall C, Hardt U, Gustafsson JT, Elvin K, Jensen-Urstad K, Kvarnström M, Grosso G, Rönnelid J, Padykov L, Gunnarsson I, Silverman GJ, Svenungsson E.

Clin Immunol. 2017 Oct;183:304-315. doi: 10.1016/j.clim.2017.09.013. Epub 2017 Sep 15.

PMID:
28919518
33.

Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.

Rossides M, Simard JF, Svenungsson E, von Euler M, Arkema EV.

J Rheumatol. 2017 Nov;44(11):1590-1596. doi: 10.3899/jrheum.170241. Epub 2017 Sep 15.

PMID:
28916550
34.

Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics.

Surowiec I, Johansson E, Torell F, Idborg H, Gunnarsson I, Svenungsson E, Jakobsson PJ, Trygg J.

Metabolomics. 2017;13(10):114. doi: 10.1007/s11306-017-1248-1. Epub 2017 Aug 24.

35.

Novel risk genes for systemic lupus erythematosus predicted by random forest classification.

Almlöf JC, Alexsson A, Imgenberg-Kreuz J, Sylwan L, Bäcklin C, Leonard D, Nordmark G, Tandre K, Eloranta ML, Padyukov L, Bengtsson C, Jönsen A, Dahlqvist SR, Sjöwall C, Bengtsson AA, Gunnarsson I, Svenungsson E, Rönnblom L, Sandling JK, Syvänen AC.

Sci Rep. 2017 Jul 24;7(1):6236. doi: 10.1038/s41598-017-06516-1.

36.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

37.

Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).

Grosso G, Vikerfors A, Woodhams B, Adam M, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Svenungsson E, Antovic A.

Thromb Res. 2017 Oct;158:168-173. doi: 10.1016/j.thromres.2017.06.028. Epub 2017 Jun 24.

PMID:
28669410
38.

Altered β2 -glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies.

Mobarrez F, Gunnarsson I, Svenungsson E.

J Thromb Haemost. 2017 Sep;15(9):1799-1806. doi: 10.1111/jth.13765. Epub 2017 Aug 17.

39.

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).

Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, Svenungsson E.

Arthritis Res Ther. 2017 Jun 15;19(1):139. doi: 10.1186/s13075-017-1344-7.

40.

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Olsson LM, Johansson ÅC, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson E, Gunnarsson I, Bengtsson AA, Holmdahl R.

Ann Rheum Dis. 2017 Sep;76(9):1607-1613. doi: 10.1136/annrheumdis-2017-211287. Epub 2017 Jun 12.

PMID:
28606963
41.

Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.

Gustafsson JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, Elvin K, Öhrvik J, Larsson A, Jensen-Urstad K, Svenungsson E.

PLoS One. 2017 Apr 17;12(4):e0174572. doi: 10.1371/journal.pone.0174572. eCollection 2017.

42.

Stroke in systemic lupus erythematosus: a Swedish population-based cohort study.

Arkema EV, Svenungsson E, Von Euler M, Sjöwall C, Simard JF.

Ann Rheum Dis. 2017 Sep;76(9):1544-1549. doi: 10.1136/annrheumdis-2016-210973. Epub 2017 Apr 11.

43.

Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls.

Pettersson H, Åkerström A, Nordin A, Svenungsson E, Alexanderson H, Boström C.

Scand J Rheumatol. 2017 Nov;46(6):490-495. doi: 10.1080/03009742.2017.1281436. Epub 2017 Mar 17.

PMID:
28303747
44.

A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.

Pettersson S, Svenungsson E, Gustafsson J, Möller S, Gunnarsson I, Welin Henriksson E.

Scand J Rheumatol. 2017 Nov;46(6):474-483. doi: 10.1080/03009742.2016.1276959. Epub 2017 Mar 15.

PMID:
28293972
45.

Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.

Arnaud L, Nordin A, Lundholm H, Svenungsson E, Hellbacher E, Wikner J, Zickert A, Gunnarsson I.

Arthritis Rheumatol. 2017 Jun;69(6):1272-1279. doi: 10.1002/art.40057. Epub 2017 May 4.

46.

Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study.

Checa A, Idborg H, Zandian A, Sar DG, Surowiec I, Trygg J, Svenungsson E, Jakobsson PJ, Nilsson P, Gunnarsson I, Wheelock CE.

Lupus. 2017 Sep;26(10):1023-1033. doi: 10.1177/0961203316686707. Epub 2017 Jan 29.

PMID:
28134039
47.

Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.

Parodis I, Ding H, Zickert A, Arnaud L, Larsson A, Svenungsson E, Mohan C, Gunnarsson I.

Scand J Rheumatol. 2017 Jul;46(4):263-272. doi: 10.1080/03009742.2016.1231339. Epub 2016 Dec 15.

PMID:
27973968
48.

Early-onset Preeclampsia in Lupus Pregnancy.

Simard JF, Arkema EV, Nguyen C, Svenungsson E, Wikström AK, Palmsten K, Salmon JE.

Paediatr Perinat Epidemiol. 2017 Jan;31(1):29-36. doi: 10.1111/ppe.12332. Epub 2016 Dec 12.

49.

Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Zickert A, Oke V, Parodis I, Svenungsson E, Sundström Y, Gunnarsson I.

Lupus Sci Med. 2016 Nov 22;3(1):e000170. eCollection 2016.

50.

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.

Mobarrez F, Vikerfors A, Gustafsson JT, Gunnarsson I, Zickert A, Larsson A, Pisetsky DS, Wallén H, Svenungsson E.

Sci Rep. 2016 Oct 25;6:36025. doi: 10.1038/srep36025.

Supplemental Content

Loading ...
Support Center